Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03796767

Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer

Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer (SOAR)

Status
Active Not Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of Utah · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This phase II trial studies how well surgery and radiation therapy work in treating patients with prostate cancer that has come back or spread to other parts of the body. Radiation therapy uses high energy beams to kill tumor cells and shrink tumors. Surgical procedures, such as oligometastasectomy, may remove tumor cells that have spread to other parts of the body. Surgery and radiation therapy may work better in treating patients with prostate cancer that has come back or spread to other parts of the body.

Detailed description

PRIMARY OBJECTIVES: I. To assess response to treatment of oligometastatic disease. SECONDARY OBJECTIVES: I. To assess additional measurements of response to treatment of oligometastatic disease. II. To assess prostate-specific antigen (PSA) progression free-survival following treatment of oligometastatic disease. III. To assess time to disease recurrence following treatment of oligometastatic disease. IV. To assess time to initiation of antiandrogen therapy (ADT) for metastatic prostate cancer following treatment of oligometastatic disease. V. To assess the rate of undetectable PSA following treatment of oligometastatic disease in subjects who have previously undergone prostatectomy. VI. To assess safety. VII. To assess the impact of study treatment on change in quality of life over three years.

Conditions

Interventions

TypeNameDescription
RADIATIONHypofractionated Radiation TherapyUndergo hypofractionated radiation therapy
RADIATIONIntensity-Modulated Radiation TherapyUndergo IMRT
PROCEDUREMetastasectomyUndergo salvage oligometastasectomy
OTHERQuality-of-Life AssessmentAncillary studies
OTHERQuestionnaire AdministrationAncillary studies
RADIATIONStereotactic Body Radiation TherapyUndergo SBRT

Timeline

Start date
2019-09-09
Primary completion
2024-02-13
Completion
2026-06-30
First posted
2019-01-08
Last updated
2026-01-28
Results posted
2025-10-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03796767. Inclusion in this directory is not an endorsement.